In a letter to congressional leadership, ACCC joined 16 other healthcare associations and coalitions urging Congress to extend Medicare's 5 percent advanced alternative payment model (APM) incentive payments in an end-of-year legislative package. Originally authorized under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), these incentive payments were intended to support providers in making the transition to value-based care delivery and participating in these models through CY 2022, recognizing the significant upfront and ongoing investment necessary for participation. Absent congressional action, providers participating in advanced APMs, including the Enhancing Oncology Model, will not be eligible to qualify for these payments in CY 2023 and beyond.